摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3'-O-acetyl-5'-deoxy-5'-iodothymidine | 14046-57-2

中文名称
——
中文别名
——
英文名称
3'-O-acetyl-5'-deoxy-5'-iodothymidine
英文别名
[(2S,3S,5R)-2-(iodomethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] acetate
3'-O-acetyl-5'-deoxy-5'-iodothymidine化学式
CAS
14046-57-2
化学式
C12H15IN2O5
mdl
——
分子量
394.166
InChiKey
OKGXADXFWVNMFM-IVZWLZJFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    131 °C
  • 密度:
    1.77±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    84.9
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
    申请人:Cheng Yung-chi
    公开号:US09126971B2
    公开(公告)日:2015-09-08
    The present invention relates to novel compounds according to the general formulas I, II, III, IV or V: wherein B is nucleoside base according to the structure: and the remaining variables as defined in the specification, and pharmaceutical compositions comprising the compounds. The compounds are useful interalia as anti-viral agents in viral therapy.
    本发明涉及根据一般式I、II、III、IV或V的新化合物: 其中B是根据以下结构的核苷酸碱基: 以及规范中定义的其余变量,以及包含这些化合物的药物组合物。这些化合物可用作抗病毒剂,用于病毒治疗。
  • Ring Opening of 4‘,5‘-Epoxynucleosides:  A Novel Stereoselective Entry to 4‘-<i>C</i>-Branched Nucleosides
    作者:Kazuhiro Haraguchi、Shingo Takeda、Hiromichi Tanaka
    DOI:10.1021/ol020259h
    日期:2003.5.1
    Stereoselective synthesis of 4'-alpha-carbon-substituted nucleosides has been accomplished through epoxidation of 4',5'-unsaturated nucleosides with dimethyldioxirane (DMDO) and successive SnCl(4)-promoted ring opening of the resulting 4',5'-epoxynucleosides with organosilicon reagents. [reaction: see text]
    立体选择性合成4'-α-取代的核苷已通过4',5'-不饱和核苷与二甲基二环氧乙烷DMDO)的环化和连续的SnCl(4)促进所得4',5'-的开环而完成环核苷与有机试剂。[反应:看文字]
  • Synthesis of 5′-phosphonate linked thymidine deoxyoligonucleotides
    作者:Thomas Kofoed、Marvin H. Caruthers
    DOI:10.1016/0040-4039(96)01437-2
    日期:1996.9
    idine was synthesized and coupled with 3′-deoxy-3′-hydroxy-methylthymidine to yield a 3′-COP-5′ linked thymidine dinucleotide. This dimer as its 3′-phosphoramidite was used to synthesize deoxyoligonucleotides.
    合成了5'--5'-膦基胸苷,并与3'--3'-羟基-甲基胸苷偶联,得到3'-CO-5P-5'连接的胸苷核苷酸。该二聚体作为其3'-亚酰胺被用于合成核苷酸
  • Stereospecific coupling reaction for internucleotide methyl phosphonothioate linkage
    作者:Alexander V. Lebedev、Jason P. Rife、Howard W. Seligsohn、George R. Wenzinger、Eric Wickstrom
    DOI:10.1016/s0040-4039(00)94646-x
    日期:1990.1
    5′-dimethoxytritylthymidyl-(3′–5′)methylphosphono-5′-thio-3′-acetylthymidine were prepared by the stereospecific reaction of 5′-deoxy-5′-iodo-3′-acetylthymidine with the (Sp)- or (Rp)- diastereomers of 5′-dimethoxytritylthymidyl-3′methylphosphonothioate (Li+ salt) in DMF. At 50°C, the coupling reaction was complete within 6 hours.
    通过5'--5'-的立体定向反应制备5'-二甲基三甲基嘧啶基-(3'-5')甲基膦酰基-5'-代-3'-乙酰胸苷的(Sp)-和(Rp)-非对映异构体。3'-乙酰胸苷DMF中5'-二甲基三甲基嘧啶-3'甲基硫代磷酸(Li +盐)的(Sp)-或(Rp)-非对映异构体。在50℃下,偶联反应在6小时内完成。
  • Suzuki, Yukari; Matsuda, Akira; Ueda, Tohru, Chemical and pharmaceutical bulletin, 1987, vol. 35, # 3, p. 1085 - 1092
    作者:Suzuki, Yukari、Matsuda, Akira、Ueda, Tohru
    DOI:——
    日期:——
查看更多

同类化合物

鲁西他滨 化合物 T14195 [1,1'-联苯基]-2,3,3',4,4',5'-六醇 [(2R,3R,5S)-3-(氨基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]N-[[(2R,3S,5R)-3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]氨基甲酸酯 9-(2-S-苯甲基-5-脱氧-2-硫代五呋喃糖基)-9H-嘌呤-6-胺 5-脱氧胸苷 5-脱氧-5-[(碘乙酰基)氨基]-胸腺嘧啶脱氧核苷 5-碘-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-2,5-二脱氧腺苷酸 5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷 5-三氟乙酰氨基-5-脱氧胸腺嘧啶脱氧核苷 5'-脱氧-5'氟胸苷 5'-脱氧-5'-氯胸苷-3'-(4-硝基苯基)硫代磷酸酯 5'-脱氧-5'-{[4-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-{[3-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-[4-苯基-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(甲硫基)苯甲酰氨基]胸苷 5'-脱氧-5'-[4-(吡啶-3-基)-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(4-氟苯基)-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-<(苯氧基羰基)氨基>胸苷 5'-硫代-胸苷3',5'-二乙酸酯 5'-溴乙酰氨基-5'-脱氧胸苷 5'-氨基-5-碘-2',5'-二脱氧尿苷 4-氨基-1-((2R,3R,4R,5R)-4-((叔丁基二甲基硅烷基)氧基)-5-(( 2-氯-N-[[3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]乙酰胺 2-{[(2Z)-3,7-二甲基辛-2,6-二烯-1-基](亚硝基)氨基}乙醇 2,5-二脱氧腺苷 2',5'-二脱氧尿苷 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]嘧啶-2,4-二酮 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]-5-甲基嘧啶-2,4-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)嘧啶-2,4(1H,3H)-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)-5-碘嘧啶-2,4(1H,3H)-二酮 N-{9-[(2R,4S,5R)-5-Azidomethyl-4-(tert-butyl-diphenyl-silanyloxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide (Z)-4-(1-(((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3-((1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl)-1H-1,2,3-triazol-4-ylamino)-4-oxobutane-1,2-diyl dioleate 5'-[4-((1,2-distearoyl-sn-glycer-1-yl)methyl)-1H-1,2,3-triazol-1-yl]-N-3-propargylthymidine 5'-deoxy-5'-hydrazinothymidine hydrochloride N-<5'-Desoxy-thymidinyl-(5')>-phosphorsaeure-<β,β,β-trichlorethylester>-amid Acetic acid (2S,3S,5R)-2-fluoromethyl-5-(5-methyl-2-oxo-4-thioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester N-<5'-Desoxy-thymidinyl-(5')>-phosphorsaeure--amid N-<5'-Desoxy-thymidinyl-(5')>-phosphorsaeure-bis--amid N4-Benzoyl-5'-chlor-2',5'-dideoxycytidin 5'-(bromoacetamido)-2',5'-dideoxy-5-iodouridine 5'-[3-(3-methoxy-2-methyl-acryloyl)-ureido]-5'-deoxy-thymidine 3'-deoxy-5'- O-methyl-3'-(N-(L-p-methoxyphenylalanyl)amino)adenosine 1-(2-deoxy-2-fluoro-4-C-methyl-β-D-arabinofuranosyl)cytosine hydrochloride 5'-N-Isobutyloxycarbonyl-5'-amino-5'-deoxythymidin 4'-chloromethyl-2'-deoxy-2'-fluoro-3'-O-dodecanoylcytidine 3'-O-methylene-5'-deoxy-5'-thiothymidylyl-(3'->5')-N6-benzoyl-3'-O-tert-butyldimethylsilyl-2',5'-dideoxy-5'-thioadenosine